Verapamil
Description
Type: small molecule
Groups: approved
Indication: For the treatment of hypertension, angina, and cluster headache prophylaxis.
Accession Number: DB00661 ( APRD00335)
Description: A calcium channel blocker that is a class IV anti-arrhythmia agent. [PubChem]
Structure:
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Alti-verapamil - 120mg | tablet | 120 mg | oral | 31-12-1990 | 03-08-2004 | Canada |
Alti-verapamil - 80mg | tablet | 80 mg | oral | 31-12-1990 | 03-08-2004 | Canada |
Calan | tablet, film coated | 80 mg/1 | oral | 10-09-1984 | US | |
Calan | tablet, film coated | 120 mg/1 | oral | 10-09-1984 | US | |
Calan SR | tablet, film coated, extended release | 240 mg/1 | oral | 16-12-1986 | US | |
Calan SR | tablet, film coated, extended release | 120 mg/1 | oral | 06-03-1991 | US | |
Calan SR | tablet, film coated, extended release | 180 mg/1 | oral | 15-12-1989 | US | |
Covera-HS | tablet (extended-release) | 180 mg | oral | 13-11-1997 | 15-02-2013 | Canada |
Covera-HS | tablet (extended-release) | 240 mg | oral | 13-11-1997 | 15-02-2013 | Canada |
Covera-HS | tablet, extended release | 180 mg/1 | oral | 26-02-1996 | US | |
Covera-HS | tablet, extended release | 240 mg/1 | oral | 26-02-1996 | US | |
Dom-verapamil SR 240mg Tablets | tablet (extended-release) | 240 mg | oral | 16-12-1999 | Canada | |
Isoptin Inj 2.5mg/ml | liquid | 2.5 mg | intravenous | 31-12-1984 | 31-07-2007 | Canada |
Isoptin SR | tablet (extended-release) | 240 mg | oral | 31-12-1988 | Canada | |
Isoptin SR | tablet (extended-release) | 120 mg | oral | 31-12-1991 | Canada | |
Isoptin SR | tablet (extended-release) | 180 mg | oral | 21-04-1994 | Canada | |
Isoptin Tab 120mg | tablet | 120 mg | oral | 31-12-1982 | 31-07-2007 | Canada |
Isoptin Tab 80mg | tablet | 80 mg | oral | 31-12-1982 | 31-07-2007 | Canada |
Med Verapamil Tablets | tablet | 80 mg | oral | 08-03-1999 | 29-03-2011 | Canada |
Med Verapamil Tablets | tablet | 120 mg | oral | 08-03-1999 | 29-03-2011 | Canada |
Mylan-verapamil | tablet | 80 mg | oral | 25-05-1998 | Canada | |
Mylan-verapamil | tablet | 120 mg | oral | 11-05-1998 | Canada | |
Mylan-verapamil SR | tablet (extended-release) | 180 mg | oral | 31-12-1996 | Canada | |
Mylan-verapamil SR | tablet (extended-release) | 120 mg | oral | 31-12-1996 | Canada | |
Mylan-verapamil SR | tablet (extended-release) | 240 mg | oral | 31-12-1996 | Canada | |
Novo-veramil | tablet | 80 mg | oral | 31-12-1989 | Canada | |
Novo-veramil | tablet | 120 mg | oral | 31-12-1989 | Canada | |
Novo-veramil SR | tablet (extended-release) | 240 mg | oral | 31-12-1996 | Canada | |
Nu-verap SR | tablet (extended-release) | 120 mg | oral | 01-01-1970 | Canada | |
Nu-verap SR | tablet (extended-release) | 180 mg | oral | 01-01-1970 | Canada | |
Nu-verap SR | tablet (extended-release) | 240 mg | oral | 19-07-2004 | 04-09-2012 | Canada |
Nu-verap Tab 120mg | tablet | 120 mg | oral | 31-12-1990 | 04-09-2012 | Canada |
Nu-verap Tab 80mg | tablet | 80 mg | oral | 31-12-1990 | 04-09-2012 | Canada |
Penta-verapamil - 120mg | tablet | 120 mg | oral | 25-06-1997 | 30-07-2004 | Canada |
Penta-verapamil - 80mg | tablet | 80 mg | oral | 25-06-1997 | 30-07-2004 | Canada |
PHL-verapamil SR | tablet (extended-release) | 240 mg | oral | 31-05-2002 | Canada | |
PMS-verapamil SR | tablet (extended-release) | 240 mg | oral | 01-09-1999 | Canada | |
Pro-verapamil SR | tablet (extended-release) | 240 mg | oral | 09-07-2008 | Canada | |
Pro-verapamil SR | tablet (extended-release) | 120 mg | oral | 15-06-2009 | Canada | |
Pro-verapamil SR | tablet (extended-release) | 180 mg | oral | 15-06-2009 | Canada | |
Riva-verapamil SR | tablet (extended-release) | 240 mg | oral | 14-09-2005 | Canada | |
Tarka | tablet, film coated, extended release | Array | oral | 27-05-2005 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 25-06-2009 | US | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | Canada | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | 12-11-2010 | Canada |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 01-01-2009 | US | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | Canada | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | 12-11-2010 | Canada |
Taro-verapamil Tab 120mg | tablet | 120 mg | oral | 31-12-1993 | 31-08-2000 | Canada |
Taro-verapamil Tab 80mg | tablet | 80 mg | oral | 31-12-1993 | 31-08-2000 | Canada |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 30-08-2010 | US | |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 26-05-2010 | US | |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 26-05-2010 | US | |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 05-05-2010 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 120 mg/1 | oral | 24-07-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 360 mg/1 | oral | 12-02-2009 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 120 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 240 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | capsule, extended release | 100 mg/1 | oral | 25-11-1998 | US | |
Verapamil Hydrochloride | capsule, extended release | 200 mg/1 | oral | 25-11-1998 | US | |
Verapamil Hydrochloride | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verapamil Hydrochloride Injection 2.5mg/ml | solution | 2.5 mg | intravenous | 31-12-1994 | Canada | |
Verapamil Hydrochloride Injection USP | liquid | 2.5 mg | intravenous | 31-12-1995 | Canada | |
Verapamil Injection 2.5mg/ml | liquid | 2.5 mg | intravenous | 31-12-1994 | 10-08-2005 | Canada |
Verapamil SR | tablet (extended-release) | 240 mg | oral | 22-06-2009 | 20-06-2014 | Canada |
Verapamil Tab 80mg | tablet | 80 mg | oral | 31-12-1990 | 23-07-2012 | Canada |
Verapamil-120 Tab | tablet | 120 mg | oral | 31-12-1990 | 23-07-2009 | Canada |
Verelan | capsule, delayed release pellets | 120 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 240 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule (sustained-release) | 240 mg | oral | 31-12-1994 | Canada | |
Verelan | capsule, delayed release pellets | 360 mg/1 | oral | 12-06-2003 | US | |
Verelan | capsule (sustained-release) | 180 mg | oral | 31-12-1994 | Canada | |
Verelan | capsule (sustained-release) | 120 mg | oral | 31-12-1994 | Canada | |
Verelan | capsule, delayed release pellets | 240 mg/1 | oral | 12-08-2004 | US | |
Verelan | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 120 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 240 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verelan PM | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 100 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 200 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 100 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 200 mg/1 | oral | 25-11-1998 | US |
Generic Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Apo-verap SR | tablet (extended-release) | 120 mg | oral | 24-04-2003 | Canada | |
Apo-verap SR | tablet (extended-release) | 180 mg | oral | 24-04-2003 | Canada | |
Apo-verap SR | tablet (extended-release) | 240 mg | oral | 24-04-2003 | Canada | |
Apo-verap Tab 80mg | tablet | 80 mg | oral | 31-12-1989 | Canada | |
Apo-verap Tablet 120mg | tablet | 120 mg | oral | 31-12-1989 | Canada | |
Verapamil | tablet, extended release | 180 mg/1 | oral | 05-08-2011 | US | |
Verapamil | tablet, film coated, extended release | 120 mg/1 | oral | 14-01-2014 | US | |
Verapamil | tablet, film coated, extended release | 240 mg/1 | oral | 14-01-2014 | US | |
Verapamil | tablet, film coated, extended release | 120 mg/1 | oral | 19-11-2012 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 19-11-2012 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 14-01-2014 | 31-12-2015 | US |
Verapamil | tablet, film coated, extended release | 240 mg/1 | oral | 19-11-2012 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 05-02-2013 | US | |
Verapamil | tablet, film coated, extended release | 120 mg/1 | oral | 21-04-2014 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 19-11-2012 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 25-03-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 04-12-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 04-12-2014 | US | |
Verapamil Hydrochloride | tablet, extended release | 120 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 04-12-2014 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 25-03-2011 | US | |
Verapamil Hydrochloride | capsule, extended release | 120 mg/1 | oral | 22-11-2010 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 26-09-2013 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 06-05-1987 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 24-08-2011 | US | |
Verapamil Hydrochloride | capsule, extended release | 300 mg/1 | oral | 20-12-2007 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 24-04-1995 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 05-02-1996 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 25-07-2011 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 15-08-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 15-02-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 08-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 20-04-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 20-08-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 15-08-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 28-11-2000 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 01-01-2014 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 16-11-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 04-06-2012 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 20-04-2010 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 40 mg/1 | oral | 29-06-1993 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 17-12-2013 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 40 mg/1 | oral | 29-06-1993 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 25-03-2011 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 15-01-1996 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/301 | oral | 27-05-2014 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 01-09-2010 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | capsule, extended release | 120 mg/1 | oral | 19-05-1999 | US | |
Verapamil Hydrochloride | tablet | 40 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | capsule, extended release | 180 mg/1 | oral | 19-05-1999 | US | |
Verapamil Hydrochloride | capsule, extended release | 240 mg/1 | oral | 19-05-1999 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 15-04-1996 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 01-08-1992 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 12-07-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 25-03-1996 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 17-04-1998 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 01-11-2014 | US | |
Verapamil Hydrochloride | tablet, film coated | 40 mg/1 | oral | 29-06-1993 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 15-11-1998 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 10-03-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 29-01-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 23-02-2012 | US | |
Verapamil Hydrochloride | capsule, extended release | 120 mg/1 | oral | 01-10-1999 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 07-04-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 23-02-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 22-09-1997 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 25-03-1996 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 27-06-2014 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 07-12-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 14-05-2013 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 22-05-2013 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 20-10-1998 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 13-12-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 06-05-1987 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 09-05-2000 | US | |
Verapamil Hydrochloride | capsule, extended release | 100 mg/1 | oral | 07-08-2008 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 01-03-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 14-03-2013 | US | |
Verapamil Hydrochloride | capsule, extended release | 200 mg/1 | oral | 17-05-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 25-02-1997 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 15-05-2013 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 22-09-1997 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 24-04-1995 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 05-02-1996 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 10-10-1997 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | tablet | 240 mg/1 | oral | 02-10-2012 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 04-05-2011 | US | |
Verapamil Hydrochloride PM | capsule, extended release | 100 mg/1 | oral | 09-08-2007 | US | |
Verapamil Hydrochloride PM | capsule, extended release | 200 mg/1 | oral | 09-08-2007 | US | |
Verapamil Hydrochloride PM | capsule, extended release | 300 mg/1 | oral | 09-08-2007 | US |
Over the Counter Products: Not Available
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Alti-verapamil - 120mg | tablet | 120 mg | oral | 31-12-1990 | 03-08-2004 | Canada |
Alti-verapamil - 80mg | tablet | 80 mg | oral | 31-12-1990 | 03-08-2004 | Canada |
Calan | tablet, film coated | 80 mg/1 | oral | 10-09-1984 | US | |
Calan | tablet, film coated | 120 mg/1 | oral | 10-09-1984 | US | |
Calan SR | tablet, film coated, extended release | 240 mg/1 | oral | 16-12-1986 | US | |
Calan SR | tablet, film coated, extended release | 120 mg/1 | oral | 06-03-1991 | US | |
Calan SR | tablet, film coated, extended release | 180 mg/1 | oral | 15-12-1989 | US | |
Covera-HS | tablet (extended-release) | 180 mg | oral | 13-11-1997 | 15-02-2013 | Canada |
Covera-HS | tablet (extended-release) | 240 mg | oral | 13-11-1997 | 15-02-2013 | Canada |
Covera-HS | tablet, extended release | 180 mg/1 | oral | 26-02-1996 | US | |
Covera-HS | tablet, extended release | 240 mg/1 | oral | 26-02-1996 | US | |
Dom-verapamil SR 240mg Tablets | tablet (extended-release) | 240 mg | oral | 16-12-1999 | Canada | |
Isoptin Inj 2.5mg/ml | liquid | 2.5 mg | intravenous | 31-12-1984 | 31-07-2007 | Canada |
Isoptin SR | tablet (extended-release) | 240 mg | oral | 31-12-1988 | Canada | |
Isoptin SR | tablet (extended-release) | 120 mg | oral | 31-12-1991 | Canada | |
Isoptin SR | tablet (extended-release) | 180 mg | oral | 21-04-1994 | Canada | |
Isoptin Tab 120mg | tablet | 120 mg | oral | 31-12-1982 | 31-07-2007 | Canada |
Isoptin Tab 80mg | tablet | 80 mg | oral | 31-12-1982 | 31-07-2007 | Canada |
Med Verapamil Tablets | tablet | 80 mg | oral | 08-03-1999 | 29-03-2011 | Canada |
Med Verapamil Tablets | tablet | 120 mg | oral | 08-03-1999 | 29-03-2011 | Canada |
Mylan-verapamil | tablet | 80 mg | oral | 25-05-1998 | Canada | |
Mylan-verapamil | tablet | 120 mg | oral | 11-05-1998 | Canada | |
Mylan-verapamil SR | tablet (extended-release) | 180 mg | oral | 31-12-1996 | Canada | |
Mylan-verapamil SR | tablet (extended-release) | 120 mg | oral | 31-12-1996 | Canada | |
Mylan-verapamil SR | tablet (extended-release) | 240 mg | oral | 31-12-1996 | Canada | |
Novo-veramil | tablet | 80 mg | oral | 31-12-1989 | Canada | |
Novo-veramil | tablet | 120 mg | oral | 31-12-1989 | Canada | |
Novo-veramil SR | tablet (extended-release) | 240 mg | oral | 31-12-1996 | Canada | |
Nu-verap SR | tablet (extended-release) | 120 mg | oral | 01-01-1970 | Canada | |
Nu-verap SR | tablet (extended-release) | 180 mg | oral | 01-01-1970 | Canada | |
Nu-verap SR | tablet (extended-release) | 240 mg | oral | 19-07-2004 | 04-09-2012 | Canada |
Nu-verap Tab 120mg | tablet | 120 mg | oral | 31-12-1990 | 04-09-2012 | Canada |
Nu-verap Tab 80mg | tablet | 80 mg | oral | 31-12-1990 | 04-09-2012 | Canada |
Penta-verapamil - 120mg | tablet | 120 mg | oral | 25-06-1997 | 30-07-2004 | Canada |
Penta-verapamil - 80mg | tablet | 80 mg | oral | 25-06-1997 | 30-07-2004 | Canada |
PHL-verapamil SR | tablet (extended-release) | 240 mg | oral | 31-05-2002 | Canada | |
PMS-verapamil SR | tablet (extended-release) | 240 mg | oral | 01-09-1999 | Canada | |
Pro-verapamil SR | tablet (extended-release) | 240 mg | oral | 09-07-2008 | Canada | |
Pro-verapamil SR | tablet (extended-release) | 120 mg | oral | 15-06-2009 | Canada | |
Pro-verapamil SR | tablet (extended-release) | 180 mg | oral | 15-06-2009 | Canada | |
Riva-verapamil SR | tablet (extended-release) | 240 mg | oral | 14-09-2005 | Canada | |
Tarka | tablet, film coated, extended release | Array | oral | 27-05-2005 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 25-06-2009 | US | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | Canada | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | 12-11-2010 | Canada |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 22-10-1996 | US | |
Tarka | tablet, film coated, extended release | Array | oral | 01-01-2009 | US | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | Canada | |
Tarka | tablet (extended-release) | Array | oral | 15-07-2002 | 12-11-2010 | Canada |
Taro-verapamil Tab 120mg | tablet | 120 mg | oral | 31-12-1993 | 31-08-2000 | Canada |
Taro-verapamil Tab 80mg | tablet | 80 mg | oral | 31-12-1993 | 31-08-2000 | Canada |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 30-08-2010 | US | |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 26-05-2010 | US | |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 26-05-2010 | US | |
Trandolapril and Verapamil Hydrochloride | tablet, film coated, extended release | Array | oral | 05-05-2010 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Trandolapril and Verapamil Hydrochloride ER | tablet, film coated, extended release | Array | oral | 25-02-2015 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 120 mg/1 | oral | 24-07-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 360 mg/1 | oral | 12-02-2009 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 120 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 240 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | capsule, extended release | 100 mg/1 | oral | 25-11-1998 | US | |
Verapamil Hydrochloride | capsule, extended release | 200 mg/1 | oral | 25-11-1998 | US | |
Verapamil Hydrochloride | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verapamil Hydrochloride Injection 2.5mg/ml | solution | 2.5 mg | intravenous | 31-12-1994 | Canada | |
Verapamil Hydrochloride Injection USP | liquid | 2.5 mg | intravenous | 31-12-1995 | Canada | |
Verapamil Injection 2.5mg/ml | liquid | 2.5 mg | intravenous | 31-12-1994 | 10-08-2005 | Canada |
Verapamil SR | tablet (extended-release) | 240 mg | oral | 22-06-2009 | 20-06-2014 | Canada |
Verapamil Tab 80mg | tablet | 80 mg | oral | 31-12-1990 | 23-07-2012 | Canada |
Verapamil-120 Tab | tablet | 120 mg | oral | 31-12-1990 | 23-07-2009 | Canada |
Verelan | capsule, delayed release pellets | 120 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 240 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule (sustained-release) | 240 mg | oral | 31-12-1994 | Canada | |
Verelan | capsule, delayed release pellets | 360 mg/1 | oral | 12-06-2003 | US | |
Verelan | capsule (sustained-release) | 180 mg | oral | 31-12-1994 | Canada | |
Verelan | capsule (sustained-release) | 120 mg | oral | 31-12-1994 | Canada | |
Verelan | capsule, delayed release pellets | 240 mg/1 | oral | 12-08-2004 | US | |
Verelan | capsule, delayed release pellets | 180 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 120 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 240 mg/1 | oral | 29-05-1990 | US | |
Verelan | capsule, delayed release pellets | 360 mg/1 | oral | 29-05-1990 | US | |
Verelan PM | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 100 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 200 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 300 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 100 mg/1 | oral | 25-11-1998 | US | |
Verelan PM | capsule, extended release | 200 mg/1 | oral | 25-11-1998 | US |
Generic Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Apo-verap SR | tablet (extended-release) | 120 mg | oral | 24-04-2003 | Canada | |
Apo-verap SR | tablet (extended-release) | 180 mg | oral | 24-04-2003 | Canada | |
Apo-verap SR | tablet (extended-release) | 240 mg | oral | 24-04-2003 | Canada | |
Apo-verap Tab 80mg | tablet | 80 mg | oral | 31-12-1989 | Canada | |
Apo-verap Tablet 120mg | tablet | 120 mg | oral | 31-12-1989 | Canada | |
Verapamil | tablet, extended release | 180 mg/1 | oral | 05-08-2011 | US | |
Verapamil | tablet, film coated, extended release | 120 mg/1 | oral | 14-01-2014 | US | |
Verapamil | tablet, film coated, extended release | 240 mg/1 | oral | 14-01-2014 | US | |
Verapamil | tablet, film coated, extended release | 120 mg/1 | oral | 19-11-2012 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 19-11-2012 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 14-01-2014 | 31-12-2015 | US |
Verapamil | tablet, film coated, extended release | 240 mg/1 | oral | 19-11-2012 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 05-02-2013 | US | |
Verapamil | tablet, film coated, extended release | 120 mg/1 | oral | 21-04-2014 | US | |
Verapamil | tablet, film coated, extended release | 180 mg/1 | oral | 19-11-2012 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 25-03-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 04-12-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 04-12-2014 | US | |
Verapamil Hydrochloride | tablet, extended release | 120 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 04-12-2014 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 25-03-2011 | US | |
Verapamil Hydrochloride | capsule, extended release | 120 mg/1 | oral | 22-11-2010 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 26-09-2013 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 06-05-1987 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 24-08-2011 | US | |
Verapamil Hydrochloride | capsule, extended release | 300 mg/1 | oral | 20-12-2007 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 24-04-1995 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 05-02-1996 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 25-07-2011 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 15-08-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 15-02-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 08-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 20-04-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 20-08-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 15-08-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 28-11-2000 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 01-01-2014 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 16-11-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 04-06-2012 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 20-04-2010 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 40 mg/1 | oral | 29-06-1993 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 17-12-2013 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 40 mg/1 | oral | 29-06-1993 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 25-03-2011 | US | |
Verapamil Hydrochloride | tablet | 80 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 15-01-1996 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/301 | oral | 27-05-2014 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 01-09-2010 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 01-01-2012 | US | |
Verapamil Hydrochloride | capsule, extended release | 120 mg/1 | oral | 19-05-1999 | US | |
Verapamil Hydrochloride | tablet | 40 mg/1 | oral | 07-01-2011 | US | |
Verapamil Hydrochloride | capsule, extended release | 180 mg/1 | oral | 19-05-1999 | US | |
Verapamil Hydrochloride | capsule, extended release | 240 mg/1 | oral | 19-05-1999 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 15-04-1996 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 01-08-1992 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 12-07-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 25-03-1996 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 17-04-1998 | US | |
Verapamil Hydrochloride | tablet, extended release | 180 mg/1 | oral | 01-11-2014 | US | |
Verapamil Hydrochloride | tablet, film coated | 40 mg/1 | oral | 29-06-1993 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 15-11-1998 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 10-03-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 29-01-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 23-02-2012 | US | |
Verapamil Hydrochloride | capsule, extended release | 120 mg/1 | oral | 01-10-1999 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 07-04-2014 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 23-02-2012 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 22-09-1997 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 25-03-1996 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 27-06-2014 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, extended release | 240 mg/1 | oral | 07-12-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 14-05-2013 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 22-05-2013 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 20-10-1998 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet | 120 mg/1 | oral | 13-12-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 17-09-2009 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 06-05-1987 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 09-05-2000 | US | |
Verapamil Hydrochloride | capsule, extended release | 100 mg/1 | oral | 07-08-2008 | US | |
Verapamil Hydrochloride | injection, solution | 2.5 mg/mL | intravenous | 01-03-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 14-03-2013 | US | |
Verapamil Hydrochloride | capsule, extended release | 200 mg/1 | oral | 17-05-2010 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 25-02-1997 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 05-08-2011 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 15-05-2013 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 22-09-1997 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 180 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 01-10-1986 | US | |
Verapamil Hydrochloride | tablet, film coated | 80 mg/1 | oral | 24-04-1995 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 05-02-1996 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 120 mg/1 | oral | 10-10-1997 | US | |
Verapamil Hydrochloride | tablet, film coated, extended release | 240 mg/1 | oral | 01-07-2009 | US | |
Verapamil Hydrochloride | tablet | 240 mg/1 | oral | 02-10-2012 | US | |
Verapamil Hydrochloride | tablet, film coated | 120 mg/1 | oral | 04-05-2011 | US | |
Verapamil Hydrochloride PM | capsule, extended release | 100 mg/1 | oral | 09-08-2007 | US | |
Verapamil Hydrochloride PM | capsule, extended release | 200 mg/1 | oral | 09-08-2007 | US | |
Verapamil Hydrochloride PM | capsule, extended release | 300 mg/1 | oral | 09-08-2007 | US |
International Brands
- No Brands
Brand Names
- No Brands
Brand Mixtures
Brand Name | Ingredients |
---|---|
Calan | Verapamil |
Calan | Verapamil |
Calan SR | Verapamil |
Calan SR | Verapamil |
Calan SR | Verapamil |
Covera-HS | Verapamil |
Covera-HS | Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride PM | Verapamil |
Verapamil Hydrochloride PM | Verapamil |
Verapamil Hydrochloride PM | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verelan | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verelan | Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan PM | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Apo-verap Tab 80mg | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verapamil Hydrochloride Injection 2.5mg/ml | Verapamil |
Verapamil Hydrochloride Injection USP | Verapamil |
Mylan-verapamil SR | Verapamil |
Mylan-verapamil SR | Verapamil |
Mylan-verapamil SR | Verapamil |
Novo-veramil SR | Verapamil |
PMS-verapamil SR | Verapamil |
Mylan-verapamil | Verapamil |
Mylan-verapamil | Verapamil |
Tarka | Verapamil + Trandolapril |
PHL-verapamil SR | Verapamil |
Dom-verapamil SR 240mg Tablets | Verapamil |
Apo-verap SR | Verapamil |
Apo-verap SR | Verapamil |
Apo-verap SR | Verapamil |
Riva-verapamil SR | Verapamil |
Pro-verapamil SR | Verapamil |
Pro-verapamil SR | Verapamil |
Pro-verapamil SR | Verapamil |
Novo-veramil | Verapamil |
Novo-veramil | Verapamil |
Apo-verap Tablet 120mg | Verapamil |
Verapamil Tab 80mg | Verapamil |
Verapamil-120 Tab | Verapamil |
Alti-verapamil - 80mg | Verapamil |
Alti-verapamil - 120mg | Verapamil |
Nu-verap Tab 120mg | Verapamil |
Nu-verap Tab 80mg | Verapamil |
Taro-verapamil Tab 80mg | Verapamil |
Verapamil Injection 2.5mg/ml | Verapamil |
Taro-verapamil Tab 120mg | Verapamil |
Penta-verapamil - 80mg | Verapamil |
Penta-verapamil - 120mg | Verapamil |
Isoptin Tab 80mg | Verapamil |
Isoptin Tab 120mg | Verapamil |
Covera-HS | Verapamil |
Covera-HS | Verapamil |
Tarka | Verapamil + Trandolapril |
Med Verapamil Tablets | Verapamil |
Med Verapamil Tablets | Verapamil |
Tarka | Verapamil + Trandolapril |
Isoptin Inj 2.5mg/ml | Verapamil |
Nu-verap SR | Verapamil |
Verapamil SR | Verapamil |
Nu-verap SR | Verapamil |
Nu-verap SR | Verapamil |
Isoptin SR | Verapamil |
Isoptin SR | Verapamil |
Tarka | Verapamil + Trandolapril |
Isoptin SR | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Brand Name | Ingredients |
---|---|
Calan | Verapamil |
Calan | Verapamil |
Calan SR | Verapamil |
Calan SR | Verapamil |
Calan SR | Verapamil |
Covera-HS | Verapamil |
Covera-HS | Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride PM | Verapamil |
Verapamil Hydrochloride PM | Verapamil |
Verapamil Hydrochloride PM | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verelan | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verelan | Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Tarka | Trandolapril + Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride ER | Trandolapril + Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verelan PM | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan PM | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Trandolapril and Verapamil Hydrochloride | Trandolapril + Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil | Verapamil |
Verapamil Hydrochloride | Verapamil |
Apo-verap Tab 80mg | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verelan | Verapamil |
Verapamil Hydrochloride Injection 2.5mg/ml | Verapamil |
Verapamil Hydrochloride Injection USP | Verapamil |
Mylan-verapamil SR | Verapamil |
Mylan-verapamil SR | Verapamil |
Mylan-verapamil SR | Verapamil |
Novo-veramil SR | Verapamil |
PMS-verapamil SR | Verapamil |
Mylan-verapamil | Verapamil |
Mylan-verapamil | Verapamil |
Tarka | Verapamil + Trandolapril |
PHL-verapamil SR | Verapamil |
Dom-verapamil SR 240mg Tablets | Verapamil |
Apo-verap SR | Verapamil |
Apo-verap SR | Verapamil |
Apo-verap SR | Verapamil |
Riva-verapamil SR | Verapamil |
Pro-verapamil SR | Verapamil |
Pro-verapamil SR | Verapamil |
Pro-verapamil SR | Verapamil |
Novo-veramil | Verapamil |
Novo-veramil | Verapamil |
Apo-verap Tablet 120mg | Verapamil |
Verapamil Tab 80mg | Verapamil |
Verapamil-120 Tab | Verapamil |
Alti-verapamil - 80mg | Verapamil |
Alti-verapamil - 120mg | Verapamil |
Nu-verap Tab 120mg | Verapamil |
Nu-verap Tab 80mg | Verapamil |
Taro-verapamil Tab 80mg | Verapamil |
Verapamil Injection 2.5mg/ml | Verapamil |
Taro-verapamil Tab 120mg | Verapamil |
Penta-verapamil - 80mg | Verapamil |
Penta-verapamil - 120mg | Verapamil |
Isoptin Tab 80mg | Verapamil |
Isoptin Tab 120mg | Verapamil |
Covera-HS | Verapamil |
Covera-HS | Verapamil |
Tarka | Verapamil + Trandolapril |
Med Verapamil Tablets | Verapamil |
Med Verapamil Tablets | Verapamil |
Tarka | Verapamil + Trandolapril |
Isoptin Inj 2.5mg/ml | Verapamil |
Nu-verap SR | Verapamil |
Verapamil SR | Verapamil |
Nu-verap SR | Verapamil |
Nu-verap SR | Verapamil |
Isoptin SR | Verapamil |
Isoptin SR | Verapamil |
Tarka | Verapamil + Trandolapril |
Isoptin SR | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Verapamil Hydrochloride | Verapamil |
Categories
- Anti-Arrhythmia Agents
- Vasodilator Agents
- Calcium Channel Blockers
- P-glycoprotein/ABCB1 Inhibitors
- P-glycoprotein/ABCB1 Substrates
Pharmacology
Pharmacodynamics: Not Available
Mechanism of action: Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known.
Absorption: 90%
Volume of distribution: Not Available
Protein binding: 90%
Metabolism: Not Available
Route of elimination: Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days. About 3% to 4% is excreted in the urine as unchanged drug.
Half life: 2.8-7.4 hours
Clearance: Not Available
Toxicity: LD50=8 mg/kg (i.v. in mice)
Affected organisms
- Not Available
SNP Mediated Adverse Drug Reactions
- Not Available
Pharmacoeconomics
- Mylan pharmaceuticals inc
- Elan drug delivery inc
- Gd searle llc
- Fsc laboratories inc
- Abraxis pharmaceutical products
- Bedford laboratories div ben venue laboratories inc
- Hospira inc
- International medication system
- Luitpold pharmaceuticals inc
- Marsam pharmaceuticals llc
- Smith and nephew solopak div smith and nephew
- Solopak medical products inc
- Ranbaxy laboratories inc
- Glenmark generics ltd
- Ivax pharmaceuticals inc sub teva pharmaceuticals usa
- Par pharmaceutical inc
- Pliva inc
- Actavis elizabeth llc
- Heritage pharmaceuticals inc
- Mutual pharmaceutical co inc
- Sandoz inc
- Warner chilcott div warner lambert co
- Watson laboratories inc
Packagers:
- Abbott Laboratories Ltd.
- Advanced Pharmaceutical Services Inc.
- Alza Corp.
- Amerisource Health Services Corp.
- Apotheca Inc.
- A-S Medication Solutions LLC
- Atlantic Biologicals Corporation
- BASF Corp.
- Cardinal Health
- Caremark LLC
- Comprehensive Consultant Services Inc.
- Copley Chemical Co.
- Dee Stevens and Son Feeder
- Dept Health Central Pharmacy
- Direct Dispensing Inc.
- Dispensing Solutions
- Diversified Healthcare Services Inc.
- Duramed
- Elan Pharmaceuticals Inc.
- FSC Laboratories
- GD Searle LLC
- General Injectables and Vaccines Inc.
- Glenmark Generics Ltd.
- Golden State Medical Supply Inc.
- Group Health Cooperative
- H.J. Harkins Co. Inc.
- Heartland Repack Services LLC
- Hospira Inc.
- Ivax Pharmaceuticals
- Kaiser Foundation Hospital
- Lake Erie Medical and Surgical Supply
- Liberty Pharmaceuticals
- Major Pharmaceuticals
- Medisca Inc.
- Murfreesboro Pharmaceutical Nursing Supply
- Mylan
- Nucare Pharmaceuticals Inc.
- Palmetto Pharmaceuticals Inc.
- PD-Rx Pharmaceuticals Inc.
- Pfizer Inc.
- Pharmaceutical Utilization Management Program VA Inc.
- Pharmacia Inc.
- Pharmedix
- Physicians Total Care Inc.
- Preferred Pharmaceuticals Inc.
- Prepackage Specialists
- Prepak Systems Inc.
- Prescript Pharmaceuticals
- Ranbaxy Laboratories
- Remedy Repack
- Resource Optimization and Innovation LLC
- Sandhills Packaging Inc.
- Schwarz Pharma Inc.
- Southwood Pharmaceuticals
- Talbert Medical Management Corp.
- Tya Pharmaceuticals
- UDL Laboratories
- United Research Laboratories Inc.
- Vangard Labs Inc.
- Watson Pharmaceuticals
Dosage forms
Form | Route | Strength |
---|---|---|
Tablet | oral | 80 mg |
Tablet, film coated | oral | 120 mg/1 |
Tablet, film coated | oral | 80 mg/1 |
Tablet, film coated, extended release | oral | 120 mg/1 |
Tablet, film coated, extended release | oral | 180 mg/1 |
Tablet, film coated, extended release | oral | 240 mg/1 |
Tablet, extended release | oral | 180 mg/1 |
Tablet, extended release | oral | 240 mg/1 |
Tablet | oral | 120 mg |
Tablet (extended-release) | oral | 120 mg |
Tablet (extended-release) | oral | 180 mg |
Tablet (extended-release) | oral | 240 mg |
Tablet (extended-release) | oral | |
Tablet, film coated, extended release | oral | |
Capsule, extended release | oral | 120 mg/1 |
Capsule, extended release | oral | 180 mg/1 |
Capsule, extended release | oral | 240 mg/1 |
Injection, solution | intravenous | 2.5 mg/mL |
Tablet | oral | 120 mg/1 |
Tablet | oral | 240 mg/1 |
Tablet | oral | 40 mg/1 |
Tablet | oral | 80 mg/1 |
Tablet, extended release | oral | 120 mg/1 |
Tablet, extended release | oral | 240 mg/301 |
Tablet, film coated | oral | 40 mg/1 |
Solution | intravenous | 2.5 mg |
Liquid | intravenous | 2.5 mg |
Capsule (sustained-release) | oral | 120 mg |
Capsule (sustained-release) | oral | 180 mg |
Capsule (sustained-release) | oral | 240 mg |
Capsule, delayed release pellets | oral | 120 mg/1 |
Capsule, delayed release pellets | oral | 180 mg/1 |
Capsule, delayed release pellets | oral | 240 mg/1 |
Capsule, delayed release pellets | oral | 360 mg/1 |
Capsule, extended release | oral | 100 mg/1 |
Capsule, extended release | oral | 200 mg/1 |
Capsule, extended release | oral | 300 mg/1 |
Form | Route | Strength |
---|---|---|
Tablet | oral | 80 mg |
Tablet, film coated | oral | 120 mg/1 |
Tablet, film coated | oral | 80 mg/1 |
Tablet, film coated, extended release | oral | 120 mg/1 |
Tablet, film coated, extended release | oral | 180 mg/1 |
Tablet, film coated, extended release | oral | 240 mg/1 |
Tablet, extended release | oral | 180 mg/1 |
Tablet, extended release | oral | 240 mg/1 |
Tablet | oral | 120 mg |
Tablet (extended-release) | oral | 120 mg |
Tablet (extended-release) | oral | 180 mg |
Tablet (extended-release) | oral | 240 mg |
Tablet (extended-release) | oral | |
Tablet, film coated, extended release | oral | |
Capsule, extended release | oral | 120 mg/1 |
Capsule, extended release | oral | 180 mg/1 |
Capsule, extended release | oral | 240 mg/1 |
Injection, solution | intravenous | 2.5 mg/mL |
Tablet | oral | 120 mg/1 |
Tablet | oral | 240 mg/1 |
Tablet | oral | 40 mg/1 |
Tablet | oral | 80 mg/1 |
Tablet, extended release | oral | 120 mg/1 |
Tablet, extended release | oral | 240 mg/301 |
Tablet, film coated | oral | 40 mg/1 |
Solution | intravenous | 2.5 mg |
Liquid | intravenous | 2.5 mg |
Capsule (sustained-release) | oral | 120 mg |
Capsule (sustained-release) | oral | 180 mg |
Capsule (sustained-release) | oral | 240 mg |
Capsule, delayed release pellets | oral | 120 mg/1 |
Capsule, delayed release pellets | oral | 180 mg/1 |
Capsule, delayed release pellets | oral | 240 mg/1 |
Capsule, delayed release pellets | oral | 360 mg/1 |
Capsule, extended release | oral | 100 mg/1 |
Capsule, extended release | oral | 200 mg/1 |
Capsule, extended release | oral | 300 mg/1 |
Prices
Unit description | Cost | Unit |
---|---|---|
Verapamil HCl CR 120 mg Controlled Release Tabs | $1.12 | tab |
Verapamil 2.5 mg/ml vial | $1.18 | ml |
Calan 80 mg tablet | $1.25 | tablet |
Isoptin Sr 120 mg Sustained-Release Tablet | $1.34 | tablet |
Verapamil HCl CR 180 mg Controlled Release Tabs | $1.41 | tab |
Verapamil HCl CR 120 mg 24 Hour Capsule | $1.43 | capsule |
Calan sr 180 mg caplet sa | $1.46 | caplet |
Verapamil HCl CR 180 mg 24 Hour Capsule | $1.5 | capsule |
Isoptin Sr 180 mg Sustained-Release Tablet | $1.52 | tablet |
Calan 120 mg tablet | $1.56 | tablet |
Verapamil HCl CR 240 mg Controlled Release Tabs | $1.6 | tab |
Verapamil HCl CR 240 mg 24 Hour Capsule | $1.69 | capsule |
Calan sr 240 mg caplet sa | $1.77 | caplet |
Isoptin Sr 240 mg Sustained-Release Tablet | $2.03 | tablet |
Verapamil HCl CR 100 mg 24 Hour Capsule | $2.04 | capsule |
Verapamil HCl CR 360 mg 24 Hour Capsule | $2.1 | capsule |
Covera-hs 180 mg tablet sa | $2.11 | tablet |
Calan sr 120 mg caplet | $2.13 | caplet |
Isoptin SR 120 mg Controlled Release Tabs | $2.16 | tab |
Covera-HS 180 mg 24 Hour tablet | $2.2 | tablet |
Calan SR 120 mg Controlled Release Tabs | $2.27 | tab |
Isoptin sr 120 mg tablet | $2.29 | tablet |
Verapamil HCl CR 200 mg 24 Hour Capsule | $2.62 | capsule |
Calan sr 180 mg caplet | $2.7 | caplet |
Isoptin SR 180 mg Controlled Release Tabs | $2.74 | tab |
Calan SR 180 mg Controlled Release Tabs | $2.8 | tab |
Isoptin sr 180 mg tablet | $2.9 | tablet |
Covera-hs 240 mg tablet sa | $2.97 | tablet |
Calan sr 240 mg caplet | $3.09 | caplet |
Covera-HS 240 mg 24 Hour tablet | $3.09 | tablet |
Verelan pm 100 mg cap pellet | $3.13 | pellet |
Isoptin SR 240 mg Controlled Release Tabs | $3.14 | tab |
Calan SR 240 mg Controlled Release Tabs | $3.15 | tab |
Verapamil hcl powder | $3.24 | g |
Isoptin sr 240 mg tablet | $3.32 | tablet |
Verapamil HCl CR 300 mg 24 Hour Capsule | $3.82 | capsule |
Verelan 120 mg cap pellet | $3.87 | pellet |
Verelan pm 200 mg cap pellet | $4.04 | pellet |
Verelan 180 mg cap pellet | $4.06 | pellet |
Verelan 180 mg 24 Hour Capsule | $4.22 | capsule |
Verelan 240 mg cap pellet | $4.58 | pellet |
Verelan 240 mg 24 Hour Capsule | $4.76 | capsule |
Verelan pm 300 mg cap pellet | $5.87 | pellet |
Verelan 360 mg cap pellet | $6.73 | pellet |
Verelan 360 mg 24 Hour Capsule | $6.82 | capsule |
Verapamil 40 mg tablet | $0.28 | tablet |
Verapamil HCl 40 mg tablet | $0.29 | tablet |
Apo-Verap 80 mg Tablet | $0.29 | tablet |
Mylan-Verapamil 80 mg Tablet | $0.29 | tablet |
Nu-Verap 80 mg Tablet | $0.29 | tablet |
Verapamil 80 mg tablet | $0.31 | tablet |
Verapamil 120 mg tablet | $0.39 | tablet |
Apo-Verap 120 mg Tablet | $0.45 | tablet |
Mylan-Verapamil 120 mg Tablet | $0.45 | tablet |
Nu-Verap 120 mg Tablet | $0.45 | tablet |
Verapamil HCl 80 mg tablet | $0.56 | tablet |
Apo-Verap Sr 180 mg Sustained-Release Tablet | $0.69 | tablet |
Mylan-Verapamil Sr 180 mg Sustained-Release Tablet | $0.69 | tablet |
Verapamil HCl 120 mg tablet | $0.71 | tablet |
Apo-Verap Sr 120 mg Sustained-Release Tablet | $0.72 | tablet |
Mylan-Verapamil Sr 120 mg Sustained-Release Tablet | $0.72 | tablet |
Calan 40 mg tablet | $0.76 | tablet |
Apo-Verap Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Mylan-Verapamil Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Novo-Veramil Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Pms-Verapamil Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Unit description | Cost | Unit |
---|---|---|
Verapamil HCl CR 120 mg Controlled Release Tabs | $1.12 | tab |
Verapamil 2.5 mg/ml vial | $1.18 | ml |
Calan 80 mg tablet | $1.25 | tablet |
Isoptin Sr 120 mg Sustained-Release Tablet | $1.34 | tablet |
Verapamil HCl CR 180 mg Controlled Release Tabs | $1.41 | tab |
Verapamil HCl CR 120 mg 24 Hour Capsule | $1.43 | capsule |
Calan sr 180 mg caplet sa | $1.46 | caplet |
Verapamil HCl CR 180 mg 24 Hour Capsule | $1.5 | capsule |
Isoptin Sr 180 mg Sustained-Release Tablet | $1.52 | tablet |
Calan 120 mg tablet | $1.56 | tablet |
Verapamil HCl CR 240 mg Controlled Release Tabs | $1.6 | tab |
Verapamil HCl CR 240 mg 24 Hour Capsule | $1.69 | capsule |
Calan sr 240 mg caplet sa | $1.77 | caplet |
Isoptin Sr 240 mg Sustained-Release Tablet | $2.03 | tablet |
Verapamil HCl CR 100 mg 24 Hour Capsule | $2.04 | capsule |
Verapamil HCl CR 360 mg 24 Hour Capsule | $2.1 | capsule |
Covera-hs 180 mg tablet sa | $2.11 | tablet |
Calan sr 120 mg caplet | $2.13 | caplet |
Isoptin SR 120 mg Controlled Release Tabs | $2.16 | tab |
Covera-HS 180 mg 24 Hour tablet | $2.2 | tablet |
Calan SR 120 mg Controlled Release Tabs | $2.27 | tab |
Isoptin sr 120 mg tablet | $2.29 | tablet |
Verapamil HCl CR 200 mg 24 Hour Capsule | $2.62 | capsule |
Calan sr 180 mg caplet | $2.7 | caplet |
Isoptin SR 180 mg Controlled Release Tabs | $2.74 | tab |
Calan SR 180 mg Controlled Release Tabs | $2.8 | tab |
Isoptin sr 180 mg tablet | $2.9 | tablet |
Covera-hs 240 mg tablet sa | $2.97 | tablet |
Calan sr 240 mg caplet | $3.09 | caplet |
Covera-HS 240 mg 24 Hour tablet | $3.09 | tablet |
Verelan pm 100 mg cap pellet | $3.13 | pellet |
Isoptin SR 240 mg Controlled Release Tabs | $3.14 | tab |
Calan SR 240 mg Controlled Release Tabs | $3.15 | tab |
Verapamil hcl powder | $3.24 | g |
Isoptin sr 240 mg tablet | $3.32 | tablet |
Verapamil HCl CR 300 mg 24 Hour Capsule | $3.82 | capsule |
Verelan 120 mg cap pellet | $3.87 | pellet |
Verelan pm 200 mg cap pellet | $4.04 | pellet |
Verelan 180 mg cap pellet | $4.06 | pellet |
Verelan 180 mg 24 Hour Capsule | $4.22 | capsule |
Verelan 240 mg cap pellet | $4.58 | pellet |
Verelan 240 mg 24 Hour Capsule | $4.76 | capsule |
Verelan pm 300 mg cap pellet | $5.87 | pellet |
Verelan 360 mg cap pellet | $6.73 | pellet |
Verelan 360 mg 24 Hour Capsule | $6.82 | capsule |
Verapamil 40 mg tablet | $0.28 | tablet |
Verapamil HCl 40 mg tablet | $0.29 | tablet |
Apo-Verap 80 mg Tablet | $0.29 | tablet |
Mylan-Verapamil 80 mg Tablet | $0.29 | tablet |
Nu-Verap 80 mg Tablet | $0.29 | tablet |
Verapamil 80 mg tablet | $0.31 | tablet |
Verapamil 120 mg tablet | $0.39 | tablet |
Apo-Verap 120 mg Tablet | $0.45 | tablet |
Mylan-Verapamil 120 mg Tablet | $0.45 | tablet |
Nu-Verap 120 mg Tablet | $0.45 | tablet |
Verapamil HCl 80 mg tablet | $0.56 | tablet |
Apo-Verap Sr 180 mg Sustained-Release Tablet | $0.69 | tablet |
Mylan-Verapamil Sr 180 mg Sustained-Release Tablet | $0.69 | tablet |
Verapamil HCl 120 mg tablet | $0.71 | tablet |
Apo-Verap Sr 120 mg Sustained-Release Tablet | $0.72 | tablet |
Mylan-Verapamil Sr 120 mg Sustained-Release Tablet | $0.72 | tablet |
Calan 40 mg tablet | $0.76 | tablet |
Apo-Verap Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Mylan-Verapamil Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Novo-Veramil Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Pms-Verapamil Sr 240 mg Sustained-Release Tablet | $0.91 | tablet |
Patents
Country | Patent Number | Approved | Expires (estimated) |
---|---|---|---|
5785994 | United States | 1992-10-22 | 2009-10-22 |
6096339 | United States | 1997-04-04 | 2017-04-04 |
Interactions
Drug | Interaction |
---|---|
Abiraterone | The serum concentration of Verapamil can be increased when it is combined with Abiraterone. |
Acetaminophen | The metabolism of Verapamil can be increased when combined with Acetaminophen. |
Acetylsalicylic acid | Verapamil may increase the anticoagulant activities of Acetylsalicylic acid. |
Afatinib | The serum concentration of Afatinib can be increased when it is combined with Verapamil. |
Aldesleukin | The risk or severity of adverse effects can be increased when Aldesleukin is combined with Verapamil. |
Alfuzosin | Alfuzosin may increase the hypotensive activities of Verapamil. |
Aliskiren | The serum concentration of Aliskiren can be increased when it is combined with Verapamil. |
Amifostine | Verapamil may increase the hypotensive activities of Amifostine. |
Amiodarone | The serum concentration of Amiodarone can be increased when it is combined with Verapamil. |
Amlodipine | Amlodipine may increase the hypotensive activities of Verapamil. |
Amobarbital | The metabolism of Verapamil can be increased when combined with Amobarbital. |
Apixaban | The serum concentration of Apixaban can be increased when it is combined with Verapamil. |
Aprepitant | The serum concentration of Verapamil can be increased when it is combined with Aprepitant. |
Aripiprazole | The serum concentration of Aripiprazole can be increased when it is combined with Verapamil. |
Atorvastatin | The serum concentration of Verapamil can be increased when it is combined with Atorvastatin. |
Atosiban | The risk or severity of adverse effects can be increased when Verapamil is combined with Atosiban. |
Atracurium besylate | Verapamil may increase the neuromuscular blocking activities of Atracurium besylate. |
Avanafil | The serum concentration of Avanafil can be increased when it is combined with Verapamil. |
Azithromycin | The serum concentration of Verapamil can be increased when it is combined with Azithromycin. |
Batimastat | The metabolism of Verapamil can be decreased when combined with Batimastat. |
Bendroflumethiazide | The serum concentration of Bendroflumethiazide can be increased when it is combined with Verapamil. |
Bexarotene | The serum concentration of Verapamil can be decreased when it is combined with Bexarotene. |
Bosentan | The serum concentration of Verapamil can be decreased when it is combined with Bosentan. |
Bosutinib | The serum concentration of Bosutinib can be increased when it is combined with Verapamil. |
Brentuximab vedotin | The serum concentration of Brentuximab vedotin can be increased when it is combined with Verapamil. |
Bretylium | Bretylium may increase the bradycardic activities of Verapamil. |
Brexpiprazole | The serum concentration of Brexpiprazole can be increased when it is combined with Verapamil. |
Brimonidine | Brimonidine may increase the antihypertensive activities of Verapamil. |
Budesonide | The serum concentration of Budesonide can be increased when it is combined with Verapamil. |
Buspirone | The metabolism of Buspirone can be decreased when combined with Verapamil. |
Butabarbital | The metabolism of Verapamil can be increased when combined with Butabarbital. |
Butalbital | The metabolism of Verapamil can be increased when combined with Butalbital. |
Butethal | The metabolism of Verapamil can be increased when combined with Butethal. |
Caffeine | The metabolism of Verapamil can be increased when combined with Caffeine. |
Calcium Acetate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium Acetate. |
Calcium carbonate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium carbonate. |
Calcium Chloride | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium Chloride. |
Calcium citrate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium citrate. |
Calcium gluconate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium gluconate. |
Carbamazepine | The serum concentration of Carbamazepine can be increased when it is combined with Verapamil. |
Carfilzomib | The serum concentration of Carfilzomib can be increased when it is combined with Verapamil. |
Carvedilol | The serum concentration of Carvedilol can be increased when it is combined with Verapamil. |
Ceritinib | Verapamil may increase the bradycardic activities of Ceritinib. |
Cetirizine | The serum concentration of Cetirizine can be increased when it is combined with Verapamil. |
Cilostazol | The serum concentration of Cilostazol can be increased when it is combined with Verapamil. |
Cimetidine | The serum concentration of Verapamil can be increased when it is combined with Cimetidine. |
Ciprofloxacin | The serum concentration of Ciprofloxacin can be increased when it is combined with Verapamil. |
Cisatracurium besylate | Verapamil may increase the neuromuscular blocking activities of Cisatracurium besylate. |
Clarithromycin | The serum concentration of Verapamil can be increased when it is combined with Clarithromycin. |
Clonidine | Clonidine may increase the atrioventricular blocking (AV block) activities of Verapamil. |
Clopidogrel | The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Verapamil. |
Cobicistat | The serum concentration of Verapamil can be increased when it is combined with Cobicistat. |
Colchicine | The serum concentration of Colchicine can be increased when it is combined with Verapamil. |
Conivaptan | The serum concentration of Verapamil can be increased when it is combined with Conivaptan. |
Crizotinib | The serum concentration of Crizotinib can be increased when it is combined with Verapamil. |
Cyclosporine | The serum concentration of Cyclosporine can be increased when it is combined with Verapamil. |
Dabigatran etexilate | The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Verapamil. |
Dabrafenib | The serum concentration of Verapamil can be decreased when it is combined with Dabrafenib. |
Daclatasvir | The serum concentration of Verapamil can be increased when it is combined with Daclatasvir. |
Dantrolene | Dantrolene may increase the hyperkalemic activities of Verapamil. |
Dapoxetine | The serum concentration of Dapoxetine can be increased when it is combined with Verapamil. |
Darunavir | The serum concentration of Verapamil can be increased when it is combined with Darunavir. |
Dasatinib | The serum concentration of Verapamil can be increased when it is combined with Dasatinib. |
Daunorubicin | The serum concentration of Daunorubicin can be increased when it is combined with Verapamil. |
Deferasirox | The serum concentration of Verapamil can be decreased when it is combined with Deferasirox. |
Desloratadine | The serum concentration of Desloratadine can be increased when it is combined with Verapamil. |
Dexamethasone | The serum concentration of Dexamethasone can be increased when it is combined with Verapamil. |
Diazoxide | Diazoxide may increase the hypotensive activities of Verapamil. |
Digoxin | Verapamil may increase the atrioventricular blocking (AV block) activities of Digoxin. |
Diltiazem | The serum concentration of Diltiazem can be increased when it is combined with Verapamil. |
Dipyridamole | The serum concentration of Verapamil can be increased when it is combined with Dipyridamole. |
Disopyramide | The risk or severity of adverse effects can be increased when Verapamil is combined with Disopyramide. |
Docetaxel | The serum concentration of Docetaxel can be increased when it is combined with Verapamil. |
Dofetilide | The serum concentration of Dofetilide can be increased when it is combined with Verapamil. |
Domperidone | The serum concentration of Domperidone can be increased when it is combined with Verapamil. |
Doxazosin | Doxazosin may increase the hypotensive activities of Verapamil. |
Doxorubicin | The serum concentration of Doxorubicin can be increased when it is combined with Verapamil. |
Dronabinol | The serum concentration of Dronabinol can be increased when it is combined with Verapamil. |
Dronedarone | Verapamil may increase the atrioventricular blocking (AV block) activities of Dronedarone. |
Drospirenone | The serum concentration of Drospirenone can be increased when it is combined with Verapamil. |
Duloxetine | Verapamil may increase the orthostatic hypotensive activities of Duloxetine. |
Edoxaban | The serum concentration of Edoxaban can be increased when it is combined with Verapamil. |
Efavirenz | The serum concentration of Verapamil can be decreased when it is combined with Efavirenz. |
Eletriptan | The serum concentration of Eletriptan can be increased when it is combined with Verapamil. |
Eliglustat | The serum concentration of Eliglustat can be increased when it is combined with Verapamil. |
Eplerenone | The serum concentration of Eplerenone can be increased when it is combined with Verapamil. |
Erythromycin | The serum concentration of Verapamil can be increased when it is combined with Erythromycin. |
Esmolol | Esmolol may increase the bradycardic activities of Verapamil. |
Estradiol | The serum concentration of Estradiol can be increased when it is combined with Verapamil. |
Ethanol | The serum concentration of Ethanol can be increased when it is combined with Verapamil. |
Etoposide | The serum concentration of Etoposide can be increased when it is combined with Verapamil. |
Everolimus | The serum concentration of Everolimus can be increased when it is combined with Verapamil. |
Fentanyl | The serum concentration of Fentanyl can be increased when it is combined with Verapamil. |
Fexofenadine | The bioavailability of Fexofenadine can be increased when combined with Verapamil. |
Fingolimod | Verapamil may increase the bradycardic activities of Fingolimod. |
Flecainide | The risk or severity of adverse effects can be increased when Verapamil is combined with Flecainide. |
Flibanserin | The serum concentration of Flibanserin can be increased when it is combined with Verapamil. |
Fluconazole | The serum concentration of Verapamil can be increased when it is combined with Fluconazole. |
Flunisolide | The metabolism of Flunisolide can be decreased when combined with Verapamil. |
Fosamprenavir | The serum concentration of Fosamprenavir can be increased when it is combined with Verapamil. |
Fosaprepitant | The serum concentration of Verapamil can be increased when it is combined with Fosaprepitant. |
Fosphenytoin | The serum concentration of Fosphenytoin can be increased when it is combined with Verapamil. |
Fusidic Acid | The serum concentration of Verapamil can be increased when it is combined with Fusidic Acid. |
Halofantrine | The serum concentration of Halofantrine can be increased when it is combined with Verapamil. |
Heptabarbital | The metabolism of Verapamil can be increased when combined with Heptabarbital. |
Hexobarbital | The metabolism of Verapamil can be increased when combined with Hexobarbital. |
Hydrocodone | The serum concentration of Hydrocodone can be increased when it is combined with Verapamil. |
Hydrocortisone | The serum concentration of Hydrocortisone can be increased when it is combined with Verapamil. |
Ibrutinib | The serum concentration of Ibrutinib can be increased when it is combined with Verapamil. |
Idarubicin | The serum concentration of Idarubicin can be increased when it is combined with Verapamil. |
Idelalisib | The serum concentration of Verapamil can be increased when it is combined with Idelalisib. |
Ifosfamide | The serum concentration of the active metabolites of Ifosfamide can be reduced when Ifosfamide is used in combination with Verapamil resulting in a loss in efficacy. |
Imatinib | The serum concentration of Imatinib can be increased when it is combined with Verapamil. |
Indinavir | The serum concentration of Indinavir can be increased when it is combined with Verapamil. |
Irinotecan | The serum concentration of Irinotecan can be increased when it is combined with Verapamil. |
Isoflurophate | The metabolism of Verapamil can be decreased when combined with Isoflurophate. |
Itraconazole | The serum concentration of Verapamil can be increased when it is combined with Itraconazole. |
Ivabradine | The serum concentration of Ivabradine can be increased when it is combined with Verapamil. |
Ivacaftor | The serum concentration of Ivacaftor can be increased when it is combined with Verapamil. |
Ivermectin | The serum concentration of Ivermectin can be increased when it is combined with Verapamil. |
Ketoconazole | The serum concentration of Verapamil can be increased when it is combined with Ketoconazole. |
Lacosamide | Verapamil may increase the atrioventricular blocking (AV block) activities of Lacosamide. |
Lapatinib | The serum concentration of Lapatinib can be increased when it is combined with Verapamil. |
Ledipasvir | The serum concentration of Ledipasvir can be increased when it is combined with Verapamil. |
Levodopa | Verapamil may increase the orthostatic hypotensive activities of Levodopa. |
Lithium | Verapamil may increase the neurotoxic activities of Lithium. |
Lomitapide | The serum concentration of Lomitapide can be increased when it is combined with Verapamil. |
Loperamide | The serum concentration of Loperamide can be increased when it is combined with Verapamil. |
Lopinavir | The serum concentration of Lopinavir can be increased when it is combined with Verapamil. |
Loratadine | The serum concentration of Loratadine can be increased when it is combined with Verapamil. |
Lovastatin | The serum concentration of Lovastatin can be increased when it is combined with Verapamil. |
Luliconazole | The serum concentration of Verapamil can be increased when it is combined with Luliconazole. |
Lurasidone | The serum concentration of Lurasidone can be increased when it is combined with Verapamil. |
Magnesium chloride | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium chloride. |
Magnesium citrate | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium citrate. |
Magnesium hydroxide | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium hydroxide. |
Magnesium oxide | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium oxide. |
Magnesium salicylate | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium salicylate. |
Magnesium Sulfate | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium Sulfate. |
Mefloquine | The serum concentration of Verapamil can be increased when it is combined with Mefloquine. |
Metformin | The therapeutic efficacy of Metformin can be decreased when used in combination with Verapamil. |
Methohexital | The metabolism of Verapamil can be increased when combined with Methohexital. |
Methotrexate | The serum concentration of Methotrexate can be increased when it is combined with Verapamil. |
Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Verapamil. |
Midodrine | Verapamil may increase the bradycardic activities of Midodrine. |
Mifepristone | The serum concentration of Verapamil can be increased when it is combined with Mifepristone. |
Mirabegron | The serum concentration of Verapamil can be increased when it is combined with Mirabegron. |
Mitomycin | The serum concentration of Mitomycin can be increased when it is combined with Verapamil. |
Mitotane | The serum concentration of Verapamil can be decreased when it is combined with Mitotane. |
Molsidomine | Molsidomine may increase the hypotensive activities of Verapamil. |
Morphine | The serum concentration of Morphine can be increased when it is combined with Verapamil. |
Moxonidine | Moxonidine may increase the hypotensive activities of Verapamil. |
Nadolol | Verapamil may increase the hypotensive activities of Nadolol. |
Nafcillin | The metabolism of Verapamil can be increased when combined with Nafcillin. |
Naloxegol | The serum concentration of Naloxegol can be increased when it is combined with Verapamil. |
Nelfinavir | The serum concentration of Nelfinavir can be increased when it is combined with Verapamil. |
Netupitant | The serum concentration of Verapamil can be increased when it is combined with Netupitant. |
Nicardipine | The serum concentration of Nicardipine can be increased when it is combined with Verapamil. |
Nicorandil | Nicorandil may increase the hypotensive activities of Verapamil. |
Nilotinib | The serum concentration of Verapamil can be increased when it is combined with Nilotinib. |
Nimodipine | The serum concentration of Nimodipine can be increased when it is combined with Verapamil. |
Nintedanib | The serum concentration of Nintedanib can be increased when it is combined with Verapamil. |
Nitroprusside | Verapamil may increase the hypotensive activities of Nitroprusside. |
Norgestimate | The serum concentration of Norgestimate can be increased when it is combined with Verapamil. |
Obinutuzumab | Verapamil may increase the hypotensive activities of Obinutuzumab. |
Octreotide | Octreotide may increase the bradycardic activities of Verapamil. |
Olaparib | The serum concentration of Olaparib can be increased when it is combined with Verapamil. |
Ondansetron | The serum concentration of Ondansetron can be increased when it is combined with Verapamil. |
Oxycodone | The risk or severity of adverse effects can be increased when Verapamil is combined with Oxycodone. |
Paclitaxel | The serum concentration of Paclitaxel can be increased when it is combined with Verapamil. |
Palbociclib | The serum concentration of Verapamil can be increased when it is combined with Palbociclib. |
Paliperidone | The serum concentration of Paliperidone can be increased when it is combined with Verapamil. |
Pancuronium | Verapamil may increase the neuromuscular blocking activities of Pancuronium. |
Pazopanib | The serum concentration of Pazopanib can be increased when it is combined with Verapamil. |
Pentobarbital | The metabolism of Verapamil can be increased when combined with Pentobarbital. |
Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Verapamil. |
Phenelzine | Phenelzine may increase the hypotensive activities of Verapamil. |
Phenobarbital | The metabolism of Verapamil can be increased when combined with Phenobarbital. |
Phenoxybenzamine | Phenoxybenzamine may increase the hypotensive activities of Verapamil. |
Phentolamine | Phentolamine may increase the hypotensive activities of Verapamil. |
Phenytoin | The serum concentration of Phenytoin can be increased when it is combined with Verapamil. |
Pimecrolimus | The metabolism of Pimecrolimus can be decreased when combined with Verapamil. |
Pimozide | The serum concentration of Pimozide can be increased when it is combined with Verapamil. |
Posaconazole | The risk or severity of adverse effects can be increased when Posaconazole is combined with Verapamil. |
Prazosin | Prazosin may increase the hypotensive activities of Verapamil. |
Primidone | The metabolism of Verapamil can be increased when combined with Primidone. |
Progesterone | The serum concentration of Verapamil can be increased when it is combined with Progesterone. |
Propafenone | The serum concentration of Propafenone can be increased when it is combined with Verapamil. |
Propranolol | The serum concentration of Verapamil can be increased when it is combined with Propranolol. |
Prucalopride | The serum concentration of Prucalopride can be increased when it is combined with Verapamil. |
Quinidine | Quinidine may increase the hypotensive activities of Verapamil. |
Quinine | The serum concentration of Quinine can be increased when it is combined with Verapamil. |
Ranitidine | The serum concentration of Ranitidine can be increased when it is combined with Verapamil. |
Ranolazine | The serum concentration of Ranolazine can be increased when it is combined with Verapamil. |
Regorafenib | Regorafenib may increase the bradycardic activities of Verapamil. |
Reserpine | The serum concentration of Verapamil can be increased when it is combined with Reserpine. |
Rifabutin | The serum concentration of Verapamil can be decreased when it is combined with Rifabutin. |
Rifampicin | The serum concentration of Verapamil can be decreased when it is combined with Rifampicin. |
Rifapentine | The serum concentration of Verapamil can be decreased when it is combined with Rifapentine. |
Rifaximin | The serum concentration of Rifaximin can be increased when it is combined with Verapamil. |
Riociguat | The serum concentration of Riociguat can be increased when it is combined with Verapamil. |
Risperidone | The serum concentration of Risperidone can be increased when it is combined with Verapamil. |
Ritonavir | The serum concentration of Ritonavir can be increased when it is combined with Verapamil. |
Rituximab | Verapamil may increase the hypotensive activities of Rituximab. |
Rivaroxaban | The serum concentration of Rivaroxaban can be increased when it is combined with Verapamil. |
Rocuronium | Verapamil may increase the neuromuscular blocking activities of Rocuronium. |
Rolapitant | The serum concentration of Verapamil can be increased when it is combined with Rolapitant. |
Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Verapamil. |
Salicylate-sodium | Verapamil may increase the anticoagulant activities of Salicylate-sodium. |
Salmeterol | The serum concentration of Salmeterol can be increased when it is combined with Verapamil. |
Saquinavir | The serum concentration of Verapamil can be increased when it is combined with Saquinavir. |
Saxagliptin | The serum concentration of Saxagliptin can be increased when it is combined with Verapamil. |
Secobarbital | The metabolism of Verapamil can be increased when combined with Secobarbital. |
Silodosin | The serum concentration of Silodosin can be increased when it is combined with Verapamil. |
Siltuximab | The serum concentration of Verapamil can be decreased when it is combined with Siltuximab. |
Simeprevir | The serum concentration of Simeprevir can be increased when it is combined with Verapamil. |
Simvastatin | The serum concentration of Simvastatin can be increased when it is combined with Verapamil. |
Sirolimus | The serum concentration of Sirolimus can be increased when it is combined with Verapamil. |
Sitagliptin | The serum concentration of Sitagliptin can be increased when it is combined with Verapamil. |
Sofosbuvir | The serum concentration of Sofosbuvir can be increased when it is combined with Verapamil. |
Sonidegib | The serum concentration of Sonidegib can be increased when it is combined with Verapamil. |
St. John's Wort | The serum concentration of Verapamil can be decreased when it is combined with St. John's Wort. |
Stiripentol | The serum concentration of Verapamil can be increased when it is combined with Stiripentol. |
Sufentanil | Sufentanil may increase the bradycardic activities of Verapamil. |
Sulfisoxazole | The serum concentration of Verapamil can be increased when it is combined with Sulfisoxazole. |
Sunitinib | The serum concentration of Verapamil can be increased when it is combined with Sunitinib. |
Suvorexant | The serum concentration of Suvorexant can be increased when it is combined with Verapamil. |
Tacrolimus | The metabolism of Tacrolimus can be decreased when combined with Verapamil. |
Tadalafil | Tadalafil may increase the antihypertensive activities of Verapamil. |
Tamoxifen | The serum concentration of Verapamil can be increased when it is combined with Tamoxifen. |
Tamsulosin | Tamsulosin may increase the hypotensive activities of Verapamil. |
Telaprevir | The serum concentration of Telaprevir can be increased when it is combined with Verapamil. |
Telithromycin | Telithromycin may increase the bradycardic activities of Verapamil. |
Temsirolimus | The serum concentration of Temsirolimus can be increased when it is combined with Verapamil. |
Teniposide | The serum concentration of Teniposide can be increased when it is combined with Verapamil. |
Terazosin | Terazosin may increase the hypotensive activities of Verapamil. |
Tesmilifene | The serum concentration of Verapamil can be decreased when it is combined with Tesmilifene. |
Tipranavir | The serum concentration of Verapamil can be decreased when it is combined with Tipranavir. |
Tizanidine | The serum concentration of Tizanidine can be increased when it is combined with Verapamil. |
Tocilizumab | The serum concentration of Verapamil can be decreased when it is combined with Tocilizumab. |
Tofacitinib | Tofacitinib may increase the bradycardic activities of Verapamil. |
Tolvaptan | The serum concentration of Tolvaptan can be increased when it is combined with Verapamil. |
Topotecan | The serum concentration of Topotecan can be increased when it is combined with Verapamil. |
Trabectedin | The serum concentration of Trabectedin can be increased when it is combined with Verapamil. |
Tranylcypromine | Tranylcypromine may increase the hypotensive activities of Verapamil. |
Treprostinil | Treprostinil may increase the hypotensive activities of Verapamil. |
Ulipristal | The serum concentration of Ulipristal can be increased when it is combined with Verapamil. |
Valsartan | The risk or severity of adverse effects can be increased when Valsartan is combined with Verapamil. |
Vandetanib | The serum concentration of Verapamil can be increased when it is combined with Vandetanib. |
Vardenafil | Vardenafil may increase the antihypertensive activities of Verapamil. |
Vecuronium | Verapamil may increase the neuromuscular blocking activities of Vecuronium. |
Vemurafenib | The serum concentration of Vemurafenib can be increased when it is combined with Verapamil. |
Vilazodone | The serum concentration of Vilazodone can be increased when it is combined with Verapamil. |
Vinblastine | The serum concentration of Vinblastine can be increased when it is combined with Verapamil. |
Vincristine | The serum concentration of Vincristine can be increased when it is combined with Verapamil. |
Vindesine | The serum concentration of Vindesine can be increased when it is combined with Verapamil. |
Voriconazole | The risk or severity of adverse effects can be increased when Voriconazole is combined with Verapamil. |
Yohimbine | Yohimbine may decrease the antihypertensive activities of Verapamil. |
Zopiclone | The serum concentration of Zopiclone can be increased when it is combined with Verapamil. |
Zuclopenthixol | The serum concentration of Zuclopenthixol can be increased when it is combined with Verapamil. |
Drug | Interaction |
---|---|
Abiraterone | The serum concentration of Verapamil can be increased when it is combined with Abiraterone. |
Acetaminophen | The metabolism of Verapamil can be increased when combined with Acetaminophen. |
Acetylsalicylic acid | Verapamil may increase the anticoagulant activities of Acetylsalicylic acid. |
Afatinib | The serum concentration of Afatinib can be increased when it is combined with Verapamil. |
Aldesleukin | The risk or severity of adverse effects can be increased when Aldesleukin is combined with Verapamil. |
Alfuzosin | Alfuzosin may increase the hypotensive activities of Verapamil. |
Aliskiren | The serum concentration of Aliskiren can be increased when it is combined with Verapamil. |
Amifostine | Verapamil may increase the hypotensive activities of Amifostine. |
Amiodarone | The serum concentration of Amiodarone can be increased when it is combined with Verapamil. |
Amlodipine | Amlodipine may increase the hypotensive activities of Verapamil. |
Amobarbital | The metabolism of Verapamil can be increased when combined with Amobarbital. |
Apixaban | The serum concentration of Apixaban can be increased when it is combined with Verapamil. |
Aprepitant | The serum concentration of Verapamil can be increased when it is combined with Aprepitant. |
Aripiprazole | The serum concentration of Aripiprazole can be increased when it is combined with Verapamil. |
Atorvastatin | The serum concentration of Verapamil can be increased when it is combined with Atorvastatin. |
Atosiban | The risk or severity of adverse effects can be increased when Verapamil is combined with Atosiban. |
Atracurium besylate | Verapamil may increase the neuromuscular blocking activities of Atracurium besylate. |
Avanafil | The serum concentration of Avanafil can be increased when it is combined with Verapamil. |
Azithromycin | The serum concentration of Verapamil can be increased when it is combined with Azithromycin. |
Batimastat | The metabolism of Verapamil can be decreased when combined with Batimastat. |
Bendroflumethiazide | The serum concentration of Bendroflumethiazide can be increased when it is combined with Verapamil. |
Bexarotene | The serum concentration of Verapamil can be decreased when it is combined with Bexarotene. |
Bosentan | The serum concentration of Verapamil can be decreased when it is combined with Bosentan. |
Bosutinib | The serum concentration of Bosutinib can be increased when it is combined with Verapamil. |
Brentuximab vedotin | The serum concentration of Brentuximab vedotin can be increased when it is combined with Verapamil. |
Bretylium | Bretylium may increase the bradycardic activities of Verapamil. |
Brexpiprazole | The serum concentration of Brexpiprazole can be increased when it is combined with Verapamil. |
Brimonidine | Brimonidine may increase the antihypertensive activities of Verapamil. |
Budesonide | The serum concentration of Budesonide can be increased when it is combined with Verapamil. |
Buspirone | The metabolism of Buspirone can be decreased when combined with Verapamil. |
Butabarbital | The metabolism of Verapamil can be increased when combined with Butabarbital. |
Butalbital | The metabolism of Verapamil can be increased when combined with Butalbital. |
Butethal | The metabolism of Verapamil can be increased when combined with Butethal. |
Caffeine | The metabolism of Verapamil can be increased when combined with Caffeine. |
Calcium Acetate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium Acetate. |
Calcium carbonate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium carbonate. |
Calcium Chloride | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium Chloride. |
Calcium citrate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium citrate. |
Calcium gluconate | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium gluconate. |
Carbamazepine | The serum concentration of Carbamazepine can be increased when it is combined with Verapamil. |
Carfilzomib | The serum concentration of Carfilzomib can be increased when it is combined with Verapamil. |
Carvedilol | The serum concentration of Carvedilol can be increased when it is combined with Verapamil. |
Ceritinib | Verapamil may increase the bradycardic activities of Ceritinib. |
Cetirizine | The serum concentration of Cetirizine can be increased when it is combined with Verapamil. |
Cilostazol | The serum concentration of Cilostazol can be increased when it is combined with Verapamil. |
Cimetidine | The serum concentration of Verapamil can be increased when it is combined with Cimetidine. |
Ciprofloxacin | The serum concentration of Ciprofloxacin can be increased when it is combined with Verapamil. |
Cisatracurium besylate | Verapamil may increase the neuromuscular blocking activities of Cisatracurium besylate. |
Clarithromycin | The serum concentration of Verapamil can be increased when it is combined with Clarithromycin. |
Clonidine | Clonidine may increase the atrioventricular blocking (AV block) activities of Verapamil. |
Clopidogrel | The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Verapamil. |
Cobicistat | The serum concentration of Verapamil can be increased when it is combined with Cobicistat. |
Colchicine | The serum concentration of Colchicine can be increased when it is combined with Verapamil. |
Conivaptan | The serum concentration of Verapamil can be increased when it is combined with Conivaptan. |
Crizotinib | The serum concentration of Crizotinib can be increased when it is combined with Verapamil. |
Cyclosporine | The serum concentration of Cyclosporine can be increased when it is combined with Verapamil. |
Dabigatran etexilate | The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Verapamil. |
Dabrafenib | The serum concentration of Verapamil can be decreased when it is combined with Dabrafenib. |
Daclatasvir | The serum concentration of Verapamil can be increased when it is combined with Daclatasvir. |
Dantrolene | Dantrolene may increase the hyperkalemic activities of Verapamil. |
Dapoxetine | The serum concentration of Dapoxetine can be increased when it is combined with Verapamil. |
Darunavir | The serum concentration of Verapamil can be increased when it is combined with Darunavir. |
Dasatinib | The serum concentration of Verapamil can be increased when it is combined with Dasatinib. |
Daunorubicin | The serum concentration of Daunorubicin can be increased when it is combined with Verapamil. |
Deferasirox | The serum concentration of Verapamil can be decreased when it is combined with Deferasirox. |
Desloratadine | The serum concentration of Desloratadine can be increased when it is combined with Verapamil. |
Dexamethasone | The serum concentration of Dexamethasone can be increased when it is combined with Verapamil. |
Diazoxide | Diazoxide may increase the hypotensive activities of Verapamil. |
Digoxin | Verapamil may increase the atrioventricular blocking (AV block) activities of Digoxin. |
Diltiazem | The serum concentration of Diltiazem can be increased when it is combined with Verapamil. |
Dipyridamole | The serum concentration of Verapamil can be increased when it is combined with Dipyridamole. |
Disopyramide | The risk or severity of adverse effects can be increased when Verapamil is combined with Disopyramide. |
Docetaxel | The serum concentration of Docetaxel can be increased when it is combined with Verapamil. |
Dofetilide | The serum concentration of Dofetilide can be increased when it is combined with Verapamil. |
Domperidone | The serum concentration of Domperidone can be increased when it is combined with Verapamil. |
Doxazosin | Doxazosin may increase the hypotensive activities of Verapamil. |
Doxorubicin | The serum concentration of Doxorubicin can be increased when it is combined with Verapamil. |
Dronabinol | The serum concentration of Dronabinol can be increased when it is combined with Verapamil. |
Dronedarone | Verapamil may increase the atrioventricular blocking (AV block) activities of Dronedarone. |
Drospirenone | The serum concentration of Drospirenone can be increased when it is combined with Verapamil. |
Duloxetine | Verapamil may increase the orthostatic hypotensive activities of Duloxetine. |
Edoxaban | The serum concentration of Edoxaban can be increased when it is combined with Verapamil. |
Efavirenz | The serum concentration of Verapamil can be decreased when it is combined with Efavirenz. |
Eletriptan | The serum concentration of Eletriptan can be increased when it is combined with Verapamil. |
Eliglustat | The serum concentration of Eliglustat can be increased when it is combined with Verapamil. |
Eplerenone | The serum concentration of Eplerenone can be increased when it is combined with Verapamil. |
Erythromycin | The serum concentration of Verapamil can be increased when it is combined with Erythromycin. |
Esmolol | Esmolol may increase the bradycardic activities of Verapamil. |
Estradiol | The serum concentration of Estradiol can be increased when it is combined with Verapamil. |
Ethanol | The serum concentration of Ethanol can be increased when it is combined with Verapamil. |
Etoposide | The serum concentration of Etoposide can be increased when it is combined with Verapamil. |
Everolimus | The serum concentration of Everolimus can be increased when it is combined with Verapamil. |
Fentanyl | The serum concentration of Fentanyl can be increased when it is combined with Verapamil. |
Fexofenadine | The bioavailability of Fexofenadine can be increased when combined with Verapamil. |
Fingolimod | Verapamil may increase the bradycardic activities of Fingolimod. |
Flecainide | The risk or severity of adverse effects can be increased when Verapamil is combined with Flecainide. |
Flibanserin | The serum concentration of Flibanserin can be increased when it is combined with Verapamil. |
Fluconazole | The serum concentration of Verapamil can be increased when it is combined with Fluconazole. |
Flunisolide | The metabolism of Flunisolide can be decreased when combined with Verapamil. |
Fosamprenavir | The serum concentration of Fosamprenavir can be increased when it is combined with Verapamil. |
Fosaprepitant | The serum concentration of Verapamil can be increased when it is combined with Fosaprepitant. |
Fosphenytoin | The serum concentration of Fosphenytoin can be increased when it is combined with Verapamil. |
Fusidic Acid | The serum concentration of Verapamil can be increased when it is combined with Fusidic Acid. |
Halofantrine | The serum concentration of Halofantrine can be increased when it is combined with Verapamil. |
Heptabarbital | The metabolism of Verapamil can be increased when combined with Heptabarbital. |
Hexobarbital | The metabolism of Verapamil can be increased when combined with Hexobarbital. |
Hydrocodone | The serum concentration of Hydrocodone can be increased when it is combined with Verapamil. |
Hydrocortisone | The serum concentration of Hydrocortisone can be increased when it is combined with Verapamil. |
Ibrutinib | The serum concentration of Ibrutinib can be increased when it is combined with Verapamil. |
Idarubicin | The serum concentration of Idarubicin can be increased when it is combined with Verapamil. |
Idelalisib | The serum concentration of Verapamil can be increased when it is combined with Idelalisib. |
Ifosfamide | The serum concentration of the active metabolites of Ifosfamide can be reduced when Ifosfamide is used in combination with Verapamil resulting in a loss in efficacy. |
Imatinib | The serum concentration of Imatinib can be increased when it is combined with Verapamil. |
Indinavir | The serum concentration of Indinavir can be increased when it is combined with Verapamil. |
Irinotecan | The serum concentration of Irinotecan can be increased when it is combined with Verapamil. |
Isoflurophate | The metabolism of Verapamil can be decreased when combined with Isoflurophate. |
Itraconazole | The serum concentration of Verapamil can be increased when it is combined with Itraconazole. |
Ivabradine | The serum concentration of Ivabradine can be increased when it is combined with Verapamil. |
Ivacaftor | The serum concentration of Ivacaftor can be increased when it is combined with Verapamil. |
Ivermectin | The serum concentration of Ivermectin can be increased when it is combined with Verapamil. |
Ketoconazole | The serum concentration of Verapamil can be increased when it is combined with Ketoconazole. |
Lacosamide | Verapamil may increase the atrioventricular blocking (AV block) activities of Lacosamide. |
Lapatinib | The serum concentration of Lapatinib can be increased when it is combined with Verapamil. |
Ledipasvir | The serum concentration of Ledipasvir can be increased when it is combined with Verapamil. |
Levodopa | Verapamil may increase the orthostatic hypotensive activities of Levodopa. |
Lithium | Verapamil may increase the neurotoxic activities of Lithium. |
Lomitapide | The serum concentration of Lomitapide can be increased when it is combined with Verapamil. |
Loperamide | The serum concentration of Loperamide can be increased when it is combined with Verapamil. |
Lopinavir | The serum concentration of Lopinavir can be increased when it is combined with Verapamil. |
Loratadine | The serum concentration of Loratadine can be increased when it is combined with Verapamil. |
Lovastatin | The serum concentration of Lovastatin can be increased when it is combined with Verapamil. |
Luliconazole | The serum concentration of Verapamil can be increased when it is combined with Luliconazole. |
Lurasidone | The serum concentration of Lurasidone can be increased when it is combined with Verapamil. |
Magnesium chloride | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium chloride. |
Magnesium citrate | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium citrate. |
Magnesium hydroxide | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium hydroxide. |
Magnesium oxide | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium oxide. |
Magnesium salicylate | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium salicylate. |
Magnesium Sulfate | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium Sulfate. |
Mefloquine | The serum concentration of Verapamil can be increased when it is combined with Mefloquine. |
Metformin | The therapeutic efficacy of Metformin can be decreased when used in combination with Verapamil. |
Methohexital | The metabolism of Verapamil can be increased when combined with Methohexital. |
Methotrexate | The serum concentration of Methotrexate can be increased when it is combined with Verapamil. |
Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Verapamil. |
Midodrine | Verapamil may increase the bradycardic activities of Midodrine. |
Mifepristone | The serum concentration of Verapamil can be increased when it is combined with Mifepristone. |
Mirabegron | The serum concentration of Verapamil can be increased when it is combined with Mirabegron. |
Mitomycin | The serum concentration of Mitomycin can be increased when it is combined with Verapamil. |
Mitotane | The serum concentration of Verapamil can be decreased when it is combined with Mitotane. |
Molsidomine | Molsidomine may increase the hypotensive activities of Verapamil. |
Morphine | The serum concentration of Morphine can be increased when it is combined with Verapamil. |
Moxonidine | Moxonidine may increase the hypotensive activities of Verapamil. |
Nadolol | Verapamil may increase the hypotensive activities of Nadolol. |
Nafcillin | The metabolism of Verapamil can be increased when combined with Nafcillin. |
Naloxegol | The serum concentration of Naloxegol can be increased when it is combined with Verapamil. |
Nelfinavir | The serum concentration of Nelfinavir can be increased when it is combined with Verapamil. |
Netupitant | The serum concentration of Verapamil can be increased when it is combined with Netupitant. |
Nicardipine | The serum concentration of Nicardipine can be increased when it is combined with Verapamil. |
Nicorandil | Nicorandil may increase the hypotensive activities of Verapamil. |
Nilotinib | The serum concentration of Verapamil can be increased when it is combined with Nilotinib. |
Nimodipine | The serum concentration of Nimodipine can be increased when it is combined with Verapamil. |
Nintedanib | The serum concentration of Nintedanib can be increased when it is combined with Verapamil. |
Nitroprusside | Verapamil may increase the hypotensive activities of Nitroprusside. |
Norgestimate | The serum concentration of Norgestimate can be increased when it is combined with Verapamil. |
Obinutuzumab | Verapamil may increase the hypotensive activities of Obinutuzumab. |
Octreotide | Octreotide may increase the bradycardic activities of Verapamil. |
Olaparib | The serum concentration of Olaparib can be increased when it is combined with Verapamil. |
Ondansetron | The serum concentration of Ondansetron can be increased when it is combined with Verapamil. |
Oxycodone | The risk or severity of adverse effects can be increased when Verapamil is combined with Oxycodone. |
Paclitaxel | The serum concentration of Paclitaxel can be increased when it is combined with Verapamil. |
Palbociclib | The serum concentration of Verapamil can be increased when it is combined with Palbociclib. |
Paliperidone | The serum concentration of Paliperidone can be increased when it is combined with Verapamil. |
Pancuronium | Verapamil may increase the neuromuscular blocking activities of Pancuronium. |
Pazopanib | The serum concentration of Pazopanib can be increased when it is combined with Verapamil. |
Pentobarbital | The metabolism of Verapamil can be increased when combined with Pentobarbital. |
Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Verapamil. |
Phenelzine | Phenelzine may increase the hypotensive activities of Verapamil. |
Phenobarbital | The metabolism of Verapamil can be increased when combined with Phenobarbital. |
Phenoxybenzamine | Phenoxybenzamine may increase the hypotensive activities of Verapamil. |
Phentolamine | Phentolamine may increase the hypotensive activities of Verapamil. |
Phenytoin | The serum concentration of Phenytoin can be increased when it is combined with Verapamil. |
Pimecrolimus | The metabolism of Pimecrolimus can be decreased when combined with Verapamil. |
Pimozide | The serum concentration of Pimozide can be increased when it is combined with Verapamil. |
Posaconazole | The risk or severity of adverse effects can be increased when Posaconazole is combined with Verapamil. |
Prazosin | Prazosin may increase the hypotensive activities of Verapamil. |
Primidone | The metabolism of Verapamil can be increased when combined with Primidone. |
Progesterone | The serum concentration of Verapamil can be increased when it is combined with Progesterone. |
Propafenone | The serum concentration of Propafenone can be increased when it is combined with Verapamil. |
Propranolol | The serum concentration of Verapamil can be increased when it is combined with Propranolol. |
Prucalopride | The serum concentration of Prucalopride can be increased when it is combined with Verapamil. |
Quinidine | Quinidine may increase the hypotensive activities of Verapamil. |
Quinine | The serum concentration of Quinine can be increased when it is combined with Verapamil. |
Ranitidine | The serum concentration of Ranitidine can be increased when it is combined with Verapamil. |
Ranolazine | The serum concentration of Ranolazine can be increased when it is combined with Verapamil. |
Regorafenib | Regorafenib may increase the bradycardic activities of Verapamil. |
Reserpine | The serum concentration of Verapamil can be increased when it is combined with Reserpine. |
Rifabutin | The serum concentration of Verapamil can be decreased when it is combined with Rifabutin. |
Rifampicin | The serum concentration of Verapamil can be decreased when it is combined with Rifampicin. |
Rifapentine | The serum concentration of Verapamil can be decreased when it is combined with Rifapentine. |
Rifaximin | The serum concentration of Rifaximin can be increased when it is combined with Verapamil. |
Riociguat | The serum concentration of Riociguat can be increased when it is combined with Verapamil. |
Risperidone | The serum concentration of Risperidone can be increased when it is combined with Verapamil. |
Ritonavir | The serum concentration of Ritonavir can be increased when it is combined with Verapamil. |
Rituximab | Verapamil may increase the hypotensive activities of Rituximab. |
Rivaroxaban | The serum concentration of Rivaroxaban can be increased when it is combined with Verapamil. |
Rocuronium | Verapamil may increase the neuromuscular blocking activities of Rocuronium. |
Rolapitant | The serum concentration of Verapamil can be increased when it is combined with Rolapitant. |
Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Verapamil. |
Salicylate-sodium | Verapamil may increase the anticoagulant activities of Salicylate-sodium. |
Salmeterol | The serum concentration of Salmeterol can be increased when it is combined with Verapamil. |
Saquinavir | The serum concentration of Verapamil can be increased when it is combined with Saquinavir. |
Saxagliptin | The serum concentration of Saxagliptin can be increased when it is combined with Verapamil. |
Secobarbital | The metabolism of Verapamil can be increased when combined with Secobarbital. |
Silodosin | The serum concentration of Silodosin can be increased when it is combined with Verapamil. |
Siltuximab | The serum concentration of Verapamil can be decreased when it is combined with Siltuximab. |
Simeprevir | The serum concentration of Simeprevir can be increased when it is combined with Verapamil. |
Simvastatin | The serum concentration of Simvastatin can be increased when it is combined with Verapamil. |
Sirolimus | The serum concentration of Sirolimus can be increased when it is combined with Verapamil. |
Sitagliptin | The serum concentration of Sitagliptin can be increased when it is combined with Verapamil. |
Sofosbuvir | The serum concentration of Sofosbuvir can be increased when it is combined with Verapamil. |
Sonidegib | The serum concentration of Sonidegib can be increased when it is combined with Verapamil. |
St. John's Wort | The serum concentration of Verapamil can be decreased when it is combined with St. John's Wort. |
Stiripentol | The serum concentration of Verapamil can be increased when it is combined with Stiripentol. |
Sufentanil | Sufentanil may increase the bradycardic activities of Verapamil. |
Sulfisoxazole | The serum concentration of Verapamil can be increased when it is combined with Sulfisoxazole. |
Sunitinib | The serum concentration of Verapamil can be increased when it is combined with Sunitinib. |
Suvorexant | The serum concentration of Suvorexant can be increased when it is combined with Verapamil. |
Tacrolimus | The metabolism of Tacrolimus can be decreased when combined with Verapamil. |
Tadalafil | Tadalafil may increase the antihypertensive activities of Verapamil. |
Tamoxifen | The serum concentration of Verapamil can be increased when it is combined with Tamoxifen. |
Tamsulosin | Tamsulosin may increase the hypotensive activities of Verapamil. |
Telaprevir | The serum concentration of Telaprevir can be increased when it is combined with Verapamil. |
Telithromycin | Telithromycin may increase the bradycardic activities of Verapamil. |
Temsirolimus | The serum concentration of Temsirolimus can be increased when it is combined with Verapamil. |
Teniposide | The serum concentration of Teniposide can be increased when it is combined with Verapamil. |
Terazosin | Terazosin may increase the hypotensive activities of Verapamil. |
Tesmilifene | The serum concentration of Verapamil can be decreased when it is combined with Tesmilifene. |
Tipranavir | The serum concentration of Verapamil can be decreased when it is combined with Tipranavir. |
Tizanidine | The serum concentration of Tizanidine can be increased when it is combined with Verapamil. |
Tocilizumab | The serum concentration of Verapamil can be decreased when it is combined with Tocilizumab. |
Tofacitinib | Tofacitinib may increase the bradycardic activities of Verapamil. |
Tolvaptan | The serum concentration of Tolvaptan can be increased when it is combined with Verapamil. |
Topotecan | The serum concentration of Topotecan can be increased when it is combined with Verapamil. |
Trabectedin | The serum concentration of Trabectedin can be increased when it is combined with Verapamil. |
Tranylcypromine | Tranylcypromine may increase the hypotensive activities of Verapamil. |
Treprostinil | Treprostinil may increase the hypotensive activities of Verapamil. |
Ulipristal | The serum concentration of Ulipristal can be increased when it is combined with Verapamil. |
Valsartan | The risk or severity of adverse effects can be increased when Valsartan is combined with Verapamil. |
Vandetanib | The serum concentration of Verapamil can be increased when it is combined with Vandetanib. |
Vardenafil | Vardenafil may increase the antihypertensive activities of Verapamil. |
Vecuronium | Verapamil may increase the neuromuscular blocking activities of Vecuronium. |
Vemurafenib | The serum concentration of Vemurafenib can be increased when it is combined with Verapamil. |
Vilazodone | The serum concentration of Vilazodone can be increased when it is combined with Verapamil. |
Vinblastine | The serum concentration of Vinblastine can be increased when it is combined with Verapamil. |
Vincristine | The serum concentration of Vincristine can be increased when it is combined with Verapamil. |
Vindesine | The serum concentration of Vindesine can be increased when it is combined with Verapamil. |
Voriconazole | The risk or severity of adverse effects can be increased when Voriconazole is combined with Verapamil. |
Yohimbine | Yohimbine may decrease the antihypertensive activities of Verapamil. |
Zopiclone | The serum concentration of Zopiclone can be increased when it is combined with Verapamil. |
Zuclopenthixol | The serum concentration of Zuclopenthixol can be increased when it is combined with Verapamil. |
Food Interactions:
- Avoid alcohol.
- Avoid excessive quantities of coffee or tea (Caffeine).
- Avoid natural licorice.
- Avoid taking with grapefruit juice.
- Take with food.
Taxonomy
Super Class: Not Available
Class: Not Available
Sub Class: Not Available
Direct Parent: Not Available
Alternative Parents:
- Alkyl aryl ethers
- Anisoles
- Aralkylamines
- Benzyl cyanides
- Dimethoxybenzenes
- Hydrocarbon derivatives
- Nitriles
- Phenethylamines
- Phenylpropanes
- Trialkylamines
substituent:
- Alkyl aryl ether
- Amine
- Anisole
- Aralkylamine
- Aromatic homomonocyclic compound
- Benzyl-cyanide
- Carbonitrile
- Dimethoxybenzene
- Ether
- Hydrocarbon derivative
- Methoxybenzene
- Nitrile
- O-dimethoxybenzene
- Organonitrogen compound
- Organooxygen compound
- Phenethylamine
- Phenol ether
- Phenylbutylamine
- Phenylpropane
- Tertiary aliphatic amine
- Tertiary amine
References
General Reference: # Bellamy WT: P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol. 1996;36:161-83. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8725386
External Links:
Resource | Link |
---|---|
RxList | http://www.rxlist.com/cgi/generic/verapsr.htm |
Drugs.com | http://www.drugs.com/verapamil.html |
Resource | Link |
---|---|
RxList | http://www.rxlist.com/cgi/generic/verapsr.htm |
Drugs.com | http://www.drugs.com/verapamil.html |
ATC Codes:
- Array
AHFS Codes:
- 24:28.92
MSDS: Download